Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-03-19 18:13:26
Bergen, Norway - 19 Mars 2021: Annual General Meeting in BerGenBio ASA
(OSE:BGBIO) was virtually held on on 19 March 2021 at 15:00 hours (CET).
All proposals were resolved as presented in the notice convening the annual
general meeting distributed on 25 February 2021, as further set out in the
minutes from the annual general meeting attached hereto and available on the
Company's website: https://www.bergenbio.com/investors/general-meetings/
- END -
For further information, please contact:
ir@bergenbio.com
Richard Godfrey, CEO, BerGenBio ASA
Rune Skeie, CFO, BerGenBio ASA
rune.skeie@bergenbio.com
+47 917 86 513
Forward looking statements
This announcement may contain forward-looking statements, which as such are not
historical facts, but are based upon various assumptions, many of which are
based, in turn, upon further assumptions. These assumptions are inherently
subject to significant known and unknown risks, uncertainties and other
important factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the expectations
expressed or implied in this announcement by such forward-looking statements.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.